In contrast to the neuropathology of PD, i.e., the aggregation of α-synuclein, leading to Lewy bodies, the level of α-synuclein in CSF was lower in patients with PD than in HCs; moreover, its association with clinical features showed a discrepancy between studies [16]. The gene discussed is SNCA; the disease is Parkinson disease.